| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,839 |
6,652 |
$187K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,356 |
2,131 |
$64K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,133 |
999 |
$51K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,038 |
1,696 |
$49K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,095 |
995 |
$19K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,271 |
1,173 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
555 |
474 |
$7K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
1,292 |
1,043 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
261 |
224 |
$5K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
68 |
60 |
$2K |
| 99318 |
|
72 |
59 |
$772.63 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
50 |
38 |
$391.83 |
| 87807 |
|
36 |
35 |
$264.94 |
| 99441 |
|
25 |
24 |
$71.59 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
164 |
142 |
$58.41 |
| 81003 |
|
130 |
111 |
$19.41 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
15 |
13 |
$6.58 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
15 |
13 |
$0.00 |